XAGE
Longevity Health Holdings, Inc.
Price Chart
Latest Quote
$0.26
-0.03 (-11.38%)
Current Price
| Previous Close | $0.29 |
| Open | $0.26 |
| Day High | $0.26 |
| Day Low | $0.25 |
| Volume | 2,203 |
Stock Information
| Shares Outstanding | 2.48M |
| Total Debt | $401K |
| Cash Equivalents | $313K |
| Revenue | $1.79M |
| Net Income | $-6.83M |
| Sector | Consumer Defensive |
| Industry | Household & Personal Products |
| Market Cap | $636K |
| EPS (TTM) | $-4.06 |
| Exchange | OQB |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $723K |
| Sales | $1.79M |
| Income | $-6.83M |
| Book/sh | $-2.23 |
| Cash/sh | $0.13 |
| Employees | 10 |
Financial Ratios
| Quick Ratio | 0.04 |
| Current Ratio | 0.15 |
Returns & Margins
| ROA | -170.11% |
| Gross Margin | 67.69% |
| Operating Margin | -389.31% |
Ownership
| Insider Ownership | 36.10% |
| Institutional Ownership | 0.75% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/S | 0.35 |
| P/B | -0.12 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $0.33 |
| SMA50 | $0.33 |
| SMA200 | $0.63 |
| RSI | 42.52 |
| ATR | 0.0354 |
| Shares Float | 1.67M |
| Short Float | 0.59% |
| Short Ratio | 0.27 |
| Volatility | 0.37 |
| Rel Volume | 0.81 |
Performance History
| Week | -17.10% |
| Month | -17.36% |
| Quarter | -8.21% |
| 6 Months | -37.01% |
| YTD | -14.62% |
| Year | -92.14% |
| 3 Years | -99.92% |
| 10 Years | -99.91% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-03 | $0.26 | 2,200 |
| 2026-06-02 | $0.29 | 3,200 |
| 2026-06-01 | $0.30 | 200 |
| 2026-05-29 | $0.30 | 8,700 |
| 2026-05-28 | $0.34 | 22,300 |
| 2026-05-27 | $0.31 | 0 |
| 2026-05-26 | $0.31 | 200 |
| 2026-05-22 | $0.30 | 2,600 |
| 2026-05-21 | $0.32 | 8,100 |
| 2026-05-20 | $0.32 | 200 |
| 2026-05-19 | $0.32 | 700 |
| 2026-05-18 | $0.46 | 0 |
| 2026-05-15 | $0.46 | 1,100 |
| 2026-05-14 | $0.32 | 0 |
| 2026-05-13 | $0.32 | 400 |
| 2026-05-12 | $0.34 | 0 |
| 2026-05-11 | $0.34 | 2,400 |
| 2026-05-08 | $0.32 | 100 |
| 2026-05-07 | $0.32 | 1,500 |
| 2026-05-06 | $0.31 | 500 |
| 2026-05-05 | $0.31 | 0 |
| 2026-05-04 | $0.31 | 0 |
About Longevity Health Holdings, Inc.
Longevity Health Holdings, Inc., a bio-aesthetics company, focuses on developing, manufacturing, and marketing cosmetic skincare and haircare products. The company utilizes Carmell Secretome and Elevai Exosomes to support skin and hair health. Its Carmell Secretome consists of growth factors, proteins, and peptides extracted from allogeneic human platelets; and Elevai Exosomes constains growth factors, cytokines, peptides, and other small molecules involved in the body's natural healing process. The company also develops a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products. It has licensing agreement with Carnegie Mellon University to develop and commercialize biocompatible plasma-based plastics. The company was formerly known as Carmell Corporation and changed its name to Longevity Health Holdings, Inc. in March 2025. Longevity Health Holdings, Inc. was founded in 2008 and is headquartered in Pittsburgh, Pennsylvania.
Period:
Loading...
Income Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $6,357 | $0 | - | - |
| Cost Of Revenue | $6,357 | $0 | - | - |
| Total Revenue | $50,318 | $0 | $0 | $0 |
| Operating Revenue | $90,829 | $0 | $0 | $0 |
| Expenses | ||||
| Interest Expense | $49,015 | $889,318 | $3,749,210 | $2,499,084 |
| Total Expenses | $5,048,816 | $5,217,276 | $5,507,641 | $1,940,332 |
| Other Income Expense | $-5,700,230 | $-10,098,658 | $205,517 | $-2,039,507 |
| Other Non Operating Income Expenses | $44,798 | $68,772 | $10,922 | $37,378 |
| Net Non Operating Interest Income Expense | $-49,015 | $-889,318 | $-3,749,210 | $-2,499,084 |
| Interest Expense Non Operating | $49,015 | $889,318 | $3,749,210 | $2,499,084 |
| Operating Expense | $5,042,459 | $5,217,276 | $5,507,641 | $1,940,332 |
| Selling And Marketing Expense | $189,323 | $0 | - | - |
| General And Administrative Expense | $3,715,340 | $2,622,945 | $3,217,280 | $863,333 |
| Total Other Finance Cost | - | - | $2,044,241 | $1,783,597 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-10,650,464 | $-16,205,252 | $-9,051,334 | $-6,478,923 |
| Net Interest Income | $-49,015 | $-889,318 | $-3,749,210 | $-2,499,084 |
| Normalized Income | $-4,957,141 | $-6,037,822 | $-9,245,929 | $-4,402,038 |
| Net Income From Continuing And Discontinued Operation | $-10,368,261 | $-15,445,087 | $-9,051,334 | $-6,478,923 |
| Total Operating Income As Reported | $-4,998,498 | $-5,943,556 | $-5,507,641 | $-1,940,332 |
| Net Income Common Stockholders | $-10,368,261 | $-16,121,110 | $-9,607,835 | $-6,786,850 |
| Net Income | $-10,368,261 | $-15,445,087 | $-9,051,334 | $-6,478,923 |
| Net Income Including Noncontrolling Interests | $-10,368,261 | $-15,445,087 | $-9,051,334 | $-6,478,923 |
| Net Income Discontinuous Operations | $282,203 | $760,165 | $0 | - |
| Net Income Continuous Operations | $-10,650,464 | $-16,205,252 | $-9,051,334 | $-6,478,923 |
| Pretax Income | $-10,747,743 | $-16,205,252 | $-9,051,334 | $-6,478,923 |
| Special Income Charges | $-44,577 | $-726,280 | $-1,064,692 | $438,180 |
| Operating Income | $-4,998,498 | $-5,217,276 | $-5,507,641 | $-1,940,332 |
| Depreciation Amortization Depletion Income Statement | $83,486 | $97,113 | $94,298 | $94,162 |
| Depreciation And Amortization In Income Statement | $83,486 | $97,113 | $94,298 | $94,162 |
| Amortization Of Intangibles Income Statement | $83,486 | $97,113 | - | - |
| Gross Profit | $43,961 | $0 | - | - |
| Per Share | ||||
| Diluted EPS | $-14.70 | $-43.80 | $-14.98 | $-10.58 |
| Basic EPS | $-14.70 | $-43.80 | $-14.98 | $-10.58 |
| Other | ||||
| Tax Effect Of Unusual Items | $-51,705 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-4,756,440 | $-5,023,716 | $-5,254,163 | $-1,660,830 |
| Total Unusual Items | $-5,745,028 | $-10,167,430 | $194,595 | $-2,076,885 |
| Total Unusual Items Excluding Goodwill | $-5,745,028 | $-10,167,430 | $194,595 | $-2,076,885 |
| Reconciled Depreciation | $197,260 | $124,788 | $242,556 | $242,124 |
| EBITDA (Bullshit earnings) | $-10,501,468 | $-15,191,146 | $-5,059,568 | $-3,737,715 |
| EBIT | $-10,698,728 | $-15,315,934 | $-5,302,124 | $-3,979,839 |
| Diluted Average Shares | $712,091 | $367,372 | $641,210 | $641,210 |
| Basic Average Shares | $712,091 | $367,372 | $641,210 | $641,210 |
| Diluted NI Availto Com Stockholders | $-10,368,261 | $-16,121,110 | $-9,607,835 | $-6,786,850 |
| Tax Provision | $-97,279 | $0 | $0 | $0 |
| Other Special Charges | $44,577 | - | $1,064,692 | $-438,180 |
| Restructuring And Mergern Acquisition | $0 | $726,280 | $0 | - |
| Gain On Sale Of Security | $-5,700,451 | $-9,441,150 | $1,259,287 | $-2,515,065 |
| Amortization | $83,486 | $97,113 | - | - |
| Research And Development | $1,054,310 | $2,497,218 | $2,196,063 | $982,837 |
| Selling General And Administration | $3,904,663 | $2,622,945 | $3,217,280 | $863,333 |
| Other Gand A | $3,715,340 | $2,622,945 | $3,217,280 | $863,333 |
| Preferred Stock Dividends | - | $676,023 | $556,501 | $307,927 |
Fetched: 2026-02-02
Balance Sheet (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-4,732,303 | $24,724,823 | $-37,819,241 | $-29,610,264 |
| Total Assets | $1,473,980 | $63,948,803 | $1,748,547 | $1,557,103 |
| Total Non Current Assets | $518,426 | $1,048,689 | $1,143,007 | $1,378,399 |
| Goodwill And Other Intangible Assets | $19,641 | $24,187 | $28,702 | $33,218 |
| Other Intangible Assets | $19,641 | $24,187 | $28,702 | $33,218 |
| Current Assets | $955,554 | $62,900,114 | $605,540 | $178,704 |
| Hedging Assets Current | $0 | $5,700,451 | $0 | - |
| Assets Held For Sale Current | $0 | $53,321,372 | $0 | - |
| Current Deferred Assets | $86,314 | $0 | $394,147 | $166,342 |
| Prepaid Assets | $297,462 | $761,271 | $55,069 | $0 |
| Inventory | $108,705 | $0 | - | - |
| Receivables | $305,934 | $204,559 | $0 | - |
| Taxes Receivable | $301,838 | $204,559 | $0 | - |
| Accounts Receivable | $4,096 | $0 | - | - |
| Cash Cash Equivalents And Short Term Investments | $157,139 | $2,912,461 | $128,149 | $12,362 |
| Cash And Cash Equivalents | $157,139 | $2,912,461 | $128,149 | $12,362 |
| Cash Financial | $157,139 | $2,912,461 | $128,149 | $12,362 |
| Other Current Assets | - | - | $28,175 | - |
| Debt | ||||
| Net Debt | $84,019 | - | $2,649,629 | $8,591,992 |
| Total Debt | $638,993 | $2,136,449 | $3,735,008 | $9,686,424 |
| Long Term Debt And Capital Lease Obligation | $309,937 | $697,715 | $827,728 | $962,830 |
| Current Debt And Capital Lease Obligation | $329,056 | $1,438,734 | $2,907,280 | $8,723,594 |
| Current Debt | $241,158 | $1,288,598 | $2,777,778 | $8,603,432 |
| Other Current Borrowings | $241,158 | $1,288,598 | $2,777,778 | $8,603,432 |
| Long Term Debt | - | - | - | $922 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $6,186,642 | $39,199,793 | $39,539,086 | $31,134,149 |
| Total Non Current Liabilities Net Minority Interest | $309,937 | $697,715 | $32,243,801 | $15,330,784 |
| Current Liabilities | $5,876,705 | $38,502,078 | $7,295,285 | $15,803,365 |
| Payables And Accrued Expenses | $5,547,649 | $5,896,904 | $2,644,091 | $2,751,969 |
| Interest Payable | $1,175,845 | $1,175,845 | $477,720 | $1,880,656 |
| Payables | $4,058,091 | $4,417,234 | $2,138,732 | $871,313 |
| Accounts Payable | $4,058,091 | $4,417,234 | $2,138,732 | $871,313 |
| Other Current Liabilities | - | $29,874,831 | $826,980 | $3,838,008 |
| Derivative Product Liabilities | - | - | $0 | $33,300 |
| Equity | ||||
| Common Stock Equity | $-4,712,662 | $24,749,009 | $-37,790,539 | $-29,577,046 |
| Total Equity Gross Minority Interest | $-4,712,662 | $24,749,010 | $-37,790,539 | $-29,577,046 |
| Stockholders Equity | $-4,712,662 | $24,749,010 | $-37,790,539 | $-29,577,046 |
| Retained Earnings | $-68,871,662 | $-58,503,401 | $-42,382,291 | $-32,774,456 |
| Preferred Stock Equity | - | $1 | - | - |
| Preferred Securities Outside Stock Equity | - | $0 | $31,416,073 | $14,334,654 |
| Other | ||||
| Ordinary Shares Number | $696,846 | $769,686 | $641,210 | $641,210 |
| Share Issued | $696,846 | $769,686 | $641,210 | $641,210 |
| Tangible Book Value | $-4,732,303 | $24,724,822 | $-37,819,241 | $-29,610,264 |
| Invested Capital | $-4,471,504 | $26,037,607 | $-35,012,761 | $-20,972,692 |
| Working Capital | $-4,921,151 | $24,398,036 | $-6,689,745 | $-15,624,661 |
| Capital Lease Obligations | $397,835 | $847,851 | $957,230 | $1,082,070 |
| Total Capitalization | $-4,712,662 | $24,749,010 | $-37,790,539 | $-29,576,124 |
| Additional Paid In Capital | $64,156,909 | $83,250,101 | $4,590,855 | $3,160,491 |
| Capital Stock | $2,091 | $2,310 | $897 | $36,919 |
| Common Stock | $2,091 | $2,309 | $897 | $36,919 |
| Preferred Stock | $0 | $1 | $0 | - |
| Long Term Capital Lease Obligation | $309,937 | $697,715 | $827,728 | $961,908 |
| Current Capital Lease Obligation | $87,898 | $150,136 | $129,502 | $120,162 |
| Pensionand Other Post Retirement Benefit Plans Current | $0 | $1,291,609 | $916,934 | $489,794 |
| Current Accrued Expenses | $1,489,558 | $1,479,670 | $505,359 | $1,880,656 |
| Net PPE | $498,785 | $1,024,502 | $1,114,305 | $1,345,181 |
| Accumulated Depreciation | $-701,655 | $-622,715 | $-530,116 | $-440,334 |
| Gross PPE | $1,200,440 | $1,647,217 | $1,644,421 | $1,785,515 |
| Leases | $115,333 | $115,333 | $115,333 | $115,333 |
| Other Properties | $1,081,527 | $1,528,304 | $1,525,509 | $1,670,182 |
| Machinery Furniture Equipment | $3,580 | $3,580 | $3,579 | $0 |
| Properties | $0 | $0 | $0 | $0 |
| Treasury Shares Number | - | $0 | - | - |
Fetched: 2026-02-02
Cash Flow Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-4,388,948 | $-8,378,678 | $-3,435,871 | $-1,184,102 |
| Operating Activities | ||||
| Operating Cash Flow | $-4,388,948 | $-8,348,208 | $-3,428,707 | $-1,176,829 |
| Cash Flow From Continuing Operating Activities | $-4,388,948 | $-8,348,208 | $-3,428,707 | $-1,176,829 |
| Operating Gains Losses | $5,700,451 | $9,441,150 | $-194,595 | $2,515,065 |
| Investing Activities | ||||
| Investing Cash Flow | $-748,796 | $-30,470 | $-7,164 | $-7,273 |
| Cash Flow From Continuing Investing Activities | $-748,796 | $-30,470 | $-7,164 | $-7,273 |
| Capital Expenditure | - | $-30,470 | $-7,164 | $-7,273 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $2,687,225 | $0 | $1,064,317 | $3,194 |
| Financing Cash Flow | $2,382,422 | $11,162,990 | $3,551,658 | $1,195,314 |
| Cash Flow From Continuing Financing Activities | $2,382,422 | $11,162,990 | $3,551,658 | $1,195,314 |
| Net Other Financing Charges | $-86,314 | $12,463,644 | $-402,554 | $-166,342 |
| Net Common Stock Issuance | $2,687,225 | $0 | $-2,294 | $3,194 |
| Common Stock Issuance | $2,687,225 | $0 | $0 | $3,194 |
| Repurchase Of Capital Stock | - | $0 | $-2,294 | $0 |
| Net Preferred Stock Issuance | - | $0 | $1,064,317 | $0 |
| Preferred Stock Issuance | - | $0 | $1,064,317 | $0 |
| Other | ||||
| Repayment Of Debt | $-714,181 | $-3,201,707 | $0 | - |
| Issuance Of Debt | $495,692 | $1,859,980 | $2,745,974 | $1,124,299 |
| Interest Paid Supplemental Data | $29,466 | $283,526 | $92,593 | $0 |
| Income Tax Paid Supplemental Data | $0 | $750,000 | $0 | $0 |
| End Cash Position | $157,139 | $2,912,461 | $128,149 | $12,362 |
| Beginning Cash Position | $2,912,461 | $128,149 | $12,362 | $1,150 |
| Changes In Cash | $-2,755,322 | $2,784,312 | $115,787 | $11,212 |
| Proceeds From Stock Option Exercised | $0 | $41,073 | $146,215 | $234,163 |
| Net Issuance Payments Of Debt | $-218,489 | $-1,341,727 | $2,745,974 | $1,124,299 |
| Net Short Term Debt Issuance | $-218,489 | $-1,341,727 | $2,745,974 | $1,124,299 |
| Short Term Debt Payments | $-714,181 | $-3,201,707 | $0 | - |
| Short Term Debt Issuance | $495,692 | $1,859,980 | $2,745,974 | $1,124,299 |
| Net Business Purchase And Sale | $-748,796 | $0 | - | - |
| Purchase Of Business | $-748,796 | $0 | - | - |
| Net PPE Purchase And Sale | $0 | $-30,470 | $-7,164 | $-7,273 |
| Purchase Of PPE | $0 | $-30,470 | $-7,164 | $-7,273 |
| Change In Working Capital | $669,489 | $-3,422,254 | $2,338,501 | $952,689 |
| Change In Other Current Liabilities | $-2,606,356 | $-20,989,824 | $-124,840 | $-115,132 |
| Change In Other Current Assets | $4,662,980 | $18,966,528 | $-28,175 | $500 |
| Change In Payables And Accrued Expense | $-1,640,864 | $-534,472 | $2,546,585 | $1,057,903 |
| Change In Accrued Expense | $-1,281,721 | $460,842 | $1,486,639 | $977,583 |
| Change In Interest Payable | $0 | $-109,379 | $1,056,849 | $715,486 |
| Change In Payable | $-359,143 | $-995,314 | $1,059,946 | $80,320 |
| Change In Account Payable | $-359,143 | $-449,873 | $1,059,946 | $80,320 |
| Change In Tax Payable | $0 | $-545,441 | $0 | - |
| Change In Income Tax Payable | $0 | $-545,441 | $0 | - |
| Change In Prepaid Assets | $463,809 | $-659,927 | $-55,069 | $9,418 |
| Change In Inventory | $-108,705 | $0 | - | - |
| Change In Receivables | $-101,375 | $-204,559 | $0 | - |
| Changes In Account Receivables | $-4,096 | $0 | - | - |
| Other Non Cash Items | $-1,414,930 | $285,513 | $2,599,797 | $1,345,417 |
| Stock Based Compensation | $827,043 | $667,682 | $636,368 | $246,799 |
| Depreciation Amortization Depletion | $197,260 | $124,788 | $242,556 | $242,124 |
| Depreciation And Amortization | $197,260 | $124,788 | $242,556 | $242,124 |
| Amortization Cash Flow | $83,486 | $97,113 | $4,516 | $4,516 |
| Amortization Of Intangibles | $83,486 | $97,113 | $4,516 | $4,516 |
| Depreciation | $113,774 | $27,675 | $238,040 | $237,608 |
| Gain Loss On Investment Securities | $5,700,451 | $9,441,150 | $-1,259,287 | $2,515,065 |
| Net Income From Continuing Operations | $-10,368,261 | $-15,445,087 | $-9,051,334 | $-6,478,923 |
| Common Stock Payments | - | $0 | $-2,294 | $0 |
| Net Long Term Debt Issuance | - | - | $2,745,974 | $1,124,299 |
| Long Term Debt Issuance | - | - | $2,745,974 | $1,124,299 |
| Change In Other Working Capital | - | - | $-124,840 | $-115,132 |
Fetched: 2026-02-02